Mary Elaine Reyland

Dr. Mary Elaine Reyland leads initiatives in cancer biology and protein kinase C signaling at the University of Colorado Denver. As a distinguished professor within the SDM-Craniofacial Biology department, she is at the forefront of research exploring the intricate roles of protein kinase C-delta in salivary gland radioprotection. Her pioneering work holds significant promise for advancing targeted therapies in human diseases, particularly in the context of cancer treatment. Dr. Reyland's research is characterized by its innovative approach to understanding the molecular mechanisms that underpin cellular responses to radiation. By delving into the signaling pathways of protein kinase C, she aims to uncover new strategies to mitigate the adverse effects of radiotherapy on salivary glands, thereby improving the quality of life for patients undergoing cancer treatment. Her contributions to the field are widely recognized, and she is committed to translating her findings into clinical applications that can benefit patients worldwide. In addition to her research endeavors, Dr. Reyland is dedicated to mentoring the next generation of scientists. She actively engages with students and colleagues, fostering a collaborative environment that encourages scientific inquiry and discovery. Her passion for education and research excellence continues to inspire those around her, making her a valued member of the academic community at the University of Colorado Denver.